September 10, 2026 05:00 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
After days of silence, China confirms Xi Jinping’s India visit for BRICS Summit | Big setback for Abhishek Banerjee as CID arrests aide Sumit Roy | Firebrand Tukaram Mundhe’s Food Safety Blitz Hits ISKCON Juhu, 3 Licences Suspended | Vande Mataram row erupts in INDIA bloc: Congress objects, ally NC hits back, BJP pounces | Ahmedabad horror: Woman allegedly killed by father, brother to preserve ‘family honour’ over viral photo with male friend | MEA distances itself from Eiffel Tower-BAPS row, says dispute is ‘between entities concerned’ | Eiffel Tower staff strike after female workers 'sidelined' during Hindu group visit | ‘When will character assassination of women stop?’ Kangana Ranaut amid Udhayanidhi-Trisha row | 11 arms instead of 10! Suvendu Adhikari apologises over Durga image in Bengal govt ad amid Bageshwar Baba row | ‘Meat is core to Shakta Hinduism’: PM Modi adviser hits back at Bageshwar Baba over non-veg ban appeal
Johnson Baby Powder
Image Credit: wikipedia.org

Maharashtra FDA cancels Johnson & Johnson baby powder licence

| @indiablooms | Sep 18, 2022, at 05:06 am

Mumbai: The Maharashtra FDA has cancelled the baby talcum powder manufacturing licence of Johnson & Johnson, Mulund, after the department found it "Not Of Standard Quality".

The FDA said that the licence was cancelled after samples of the Johnson’s Baby Powder collected from Nashik and Pune failed quality checks and ordered the company to recall all its stocks from the markets.

These samples were declared by the FDA as ‘Not Of Standard Quality’ after they failed to comply with IS5339:2009 (Second Revision Amendment No. 3) Specification for Skin Powder for infants in the test pH.

In a statement, the FDA said: “The product Johnsons Baby Powder is popularly used in newborn babies. The sample declared 'Not of Standard' in pH and the use of the product may affect the health of the skin of the newborn babies.”

The firm "didn't accept the report" and challenged it in court for sending it to the Central Drugs Laboratory, the FDA said, according to media reports.

(With UNI inputs)

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.